Brent Johnson Sells 4,000 Shares of Iradimed Corp (NASDAQ:IRMD) Stock

Iradimed Corp (NASDAQ:IRMD) VP Brent Johnson sold 4,000 shares of Iradimed stock in a transaction that occurred on Wednesday, October 23rd. The shares were sold at an average price of $23.78, for a total value of $95,120.00. Following the completion of the sale, the vice president now directly owns 3,368 shares in the company, valued at approximately $80,091.04. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Brent Johnson also recently made the following trade(s):

  • On Monday, October 21st, Brent Johnson sold 2,000 shares of Iradimed stock. The shares were sold at an average price of $23.00, for a total value of $46,000.00.
  • On Friday, October 18th, Brent Johnson sold 2,000 shares of Iradimed stock. The shares were sold at an average price of $22.90, for a total value of $45,800.00.
  • On Wednesday, October 16th, Brent Johnson sold 3,000 shares of Iradimed stock. The shares were sold at an average price of $21.92, for a total value of $65,760.00.
  • On Monday, October 14th, Brent Johnson sold 1,902 shares of Iradimed stock. The shares were sold at an average price of $21.82, for a total value of $41,501.64.
  • On Friday, October 11th, Brent Johnson sold 1,300 shares of Iradimed stock. The shares were sold at an average price of $21.63, for a total value of $28,119.00.
  • On Wednesday, October 9th, Brent Johnson sold 3,000 shares of Iradimed stock. The shares were sold at an average price of $21.99, for a total value of $65,970.00.
  • On Monday, October 7th, Brent Johnson sold 2,000 shares of Iradimed stock. The shares were sold at an average price of $22.34, for a total value of $44,680.00.
  • On Friday, October 4th, Brent Johnson sold 4,000 shares of Iradimed stock. The shares were sold at an average price of $21.70, for a total value of $86,800.00.
  • On Wednesday, October 2nd, Brent Johnson sold 1,000 shares of Iradimed stock. The shares were sold at an average price of $21.00, for a total value of $21,000.00.
  • On Monday, September 30th, Brent Johnson sold 1,000 shares of Iradimed stock. The shares were sold at an average price of $21.51, for a total value of $21,510.00.

NASDAQ:IRMD opened at $23.60 on Friday. The firm has a market capitalization of $269.81 million, a price-to-earnings ratio of 54.88 and a beta of 1.56. Iradimed Corp has a twelve month low of $16.68 and a twelve month high of $30.90. The stock’s 50 day moving average price is $21.82 and its two-hundred day moving average price is $21.84. The company has a quick ratio of 9.39, a current ratio of 10.29 and a debt-to-equity ratio of 0.06.

Iradimed (NASDAQ:IRMD) last posted its quarterly earnings results on Tuesday, July 30th. The medical equipment provider reported $0.17 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.12 by $0.05. The firm had revenue of $9.23 million for the quarter, compared to analyst estimates of $8.91 million. Iradimed had a return on equity of 14.78% and a net margin of 23.92%. As a group, analysts anticipate that Iradimed Corp will post 0.67 earnings per share for the current year.

A number of brokerages recently issued reports on IRMD. Zacks Investment Research lowered Iradimed from a “buy” rating to a “hold” rating in a research report on Friday. ValuEngine raised Iradimed from a “sell” rating to a “hold” rating in a research report on Wednesday, July 31st.

Large investors have recently bought and sold shares of the business. HM Payson & Co. acquired a new position in shares of Iradimed during the 2nd quarter worth approximately $89,000. Marshall Wace LLP acquired a new position in shares of Iradimed during the 1st quarter worth approximately $241,000. Charles Schwab Investment Management Inc. increased its position in shares of Iradimed by 34.0% during the 2nd quarter. Charles Schwab Investment Management Inc. now owns 10,500 shares of the medical equipment provider’s stock worth $215,000 after purchasing an additional 2,666 shares during the last quarter. Morgan Stanley increased its position in shares of Iradimed by 14.3% during the 2nd quarter. Morgan Stanley now owns 13,118 shares of the medical equipment provider’s stock worth $268,000 after purchasing an additional 1,637 shares during the last quarter. Finally, Strs Ohio increased its position in shares of Iradimed by 7.5% during the 2nd quarter. Strs Ohio now owns 20,100 shares of the medical equipment provider’s stock worth $411,000 after purchasing an additional 1,400 shares during the last quarter. 30.91% of the stock is currently owned by hedge funds and other institutional investors.

Iradimed Company Profile

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system.

Featured Article: What is the Moving Average Convergence Divergence (MACD) oscillator?

Insider Buying and Selling by Quarter for Iradimed (NASDAQ:IRMD)

Receive News & Ratings for Iradimed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iradimed and related companies with MarketBeat.com's FREE daily email newsletter.